EMCDDA Work Programme 2012

The 2012 EMCDDA work programme aims to achieve the twin objectives of ensuring that the commitments detailed in the 2010–12 strategy are delivered and that sound foundations are laid for the agency to take on the challenges it will face in the 2013–15 period. It is therefore an important year for both planning and substantive activities. In 2012, some developmental activities will reach key milestones and new products addressing critical aspects of the European drug situation will be released. These activities will supplement the core analysis provided through the EMCDDA ́s annual reporting exercise and thereby ensure that the agency continues to provide a comprehensive review of the current European drug situation, through a set of high-quality products tailored to the differing needs of policymakers, practitioners, researchers and scientists, as well as the general public. It is important to note that the achievements envisaged in this work programme are only possible with the active participation and support of the Reitox network of national focal points who are the principal providers of data for the agency’s outputs.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.